Trials / Completed
CompletedNCT05927415
A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod
A Phase 1, Open-label, Study to Evaluate the Pharmacokinetics of Efgartigimod IV 10 mg/kg Single Dose Administered in Participants With Renal Impairment
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- argenx · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
A study to test how kidney problems influence the blood concentrations of efgartigimod
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Efgartigimod IV | Intravenous infusion of efgartigimod |
Timeline
- Start date
- 2023-07-17
- Primary completion
- 2024-06-12
- Completion
- 2024-06-12
- First posted
- 2023-07-03
- Last updated
- 2024-06-26
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT05927415. Inclusion in this directory is not an endorsement.